Prevalence of Seasonal Influenza Vaccination in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Balearic Islands (Spain) and Its Effect on COPD Exacerbations: A Population-Based Retrospective Cohort Study

International Journal of Environmental Research and Public Health
Laura Ruiz AzconaMiguel Santibáñez Margüello

Abstract

To determine the prevalence of influenza vaccination in chronic obstructive pulmonary disease (COPD) patients and its effect on COPD exacerbations, we conducted a retrospective population-based cohort study analyzing real-life data. We included all registered COPD patients ≥40 years old using respiratory medication during the study period (2012-2013). Influenza vaccination during the 2012/2013 campaign was the parameter studied. Moderate and severe exacerbations during 2013 were the dependent outcome variables. Logistic regression adjusting for age, gender, concomitant asthma diagnosis, COPD severity, smoking status, number of moderate and severe exacerbations the previous year, and comorbidities was performed, and 59.6% of the patients received seasonal influenza vaccination. The percentage of patients with exacerbations was higher among those vaccinated. Influenza vaccination had a statistically significantly negative (non-protective) crude effect favoring the risk of severe exacerbations: OR: 1.20 (95% CI; 1.05-1.37). This association diminished and lost statistical significance after adjustment: aOR: 0.93 (95% CI; 0.74-1.18). The protective effect in the analysis restricted to the epidemic period was not significant: aOR: 0...Continue Reading

References

Jan 27, 2006·The Cochrane Database of Systematic Reviews·P J PooleC J Cates
Aug 16, 2006·Journal of Evaluation in Clinical Practice·Navindra Persaud, Muhammad M Mamdani
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Klaus F RabeUNKNOWN Global Initiative for Chronic Obstructive Lung Disease
Sep 4, 2007·Lancet·Jadwiga A Wedzicha, Terence A R Seemungal
Oct 17, 2007·Annals of Internal Medicine·Jan P VandenbrouckeUNKNOWN STROBE initiative
Nov 30, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Pedro Plans-Rubió
Sep 17, 2010·The New England Journal of Medicine·John R HurstUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Oct 20, 2010·European Respiratory Review : an Official Journal of the European Respiratory Society·A Anzueto
Dec 31, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Martine HoogendoornMaureen Rutten-van Mölken
Apr 10, 2012·Human Vaccines & Immunotherapeutics·Juana María Santos-SanchoRodrigo Jiménez-García
Apr 16, 2013·Enfermedades infecciosas y microbiología clínica·Josep Montserrat-CapdevilaMònica Solanes
Aug 8, 2015·NPJ Primary Care Respiratory Medicine·Job F M van BovenThys van der Molen
Dec 17, 2016·Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation·Douglas J HsuBartolome R Celli
May 5, 2017·BMC Pulmonary Medicine·Rafik Bekkat-BerkaniNadia Meyer
Jun 27, 2018·The Cochrane Database of Systematic Reviews·Zoe KopsaftisPhillippa Poole

❮ Previous
Next ❯

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

The British Journal of General Practice : the Journal of the Royal College of General Practitioners
Erik W M A BischoffWil J H M van den Bosch
Postȩpy higieny i medycyny doświadczalnej
Małgorzata Gorska-CiebiadaJerzy Loba
© 2022 Meta ULC. All rights reserved